Seattle’s newest unicorn: Truveta lands $320M to fuel creation of massive new genome project

Truveta, a health data company based in Bellevue, Washington, announced $320 million in fresh funding to support an ambitious initiative to create a giant genomic dataset.

The company describes its new Truveta Genome Project as the largest and most diverse database of genotypic and phenotypic information ever assembled. “When we have this data, we will finally begin to address the cost of healthcare through early detection and prevention rather than chasing the never-ending challenges of chronic disease management. The impact will be profound,” said Truveta CEO Terry Myerson.

The new investment, which comes from 17 health systems, Illumina, and Regeneron, pushes Truveta’s valuation above $1 billion, making it the latest unicorn to emerge from the Seattle region.

READ THE STORY at GeekWire »